What is Polycythemia Vera?

Polycythemia Vera (PV) is a chronic bone marrow disorder in which the body produces too many red blood cells. This excessive production thickens the blood, increasing the risk of blood clots, which can lead to strokes, heart attacks, or circulation problems.

What is Polycythemia Vera? - mefact.org
What is Polycythemia Vera?

PV is considered a rare form of blood cancer that may progress silently for years before diagnosis. If left untreated, it can develop into bone marrow fibrosis or acute myeloid leukemia (AML).

1. Causes of Polycythemia Vera

The exact cause of PV is unknown, but most cases are linked to mutations in the JAK2 (Janus kinase 2) gene. This mutation causes the bone marrow to overproduce red blood cells without regulation.

Risk Factors:

  • Genetics: Though not directly inherited, individuals with a family history of blood disorders are at higher risk.
  • Gene Mutation: Around 95% of PV patients have the JAK2 V617F mutation.
  • Age: The condition is more common in individuals over 50 but can also affect younger people.
  • Gender: Men have a higher incidence rate than women.

2. Symptoms of Polycythemia Vera

PV may progress slowly, with symptoms developing over time. Common symptoms include:

  • Fatigue and weakness
  • Headaches, dizziness, and lightheadedness
  • Flushed skin, especially on the face, hands, and feet
  • Itchy skin, particularly after a hot shower
  • Burning sensation in the hands and feet
  • Easy bruising or frequent nosebleeds
  • High blood pressure
  • Enlarged spleen or liver (causing upper left abdominal discomfort)

Some patients may experience serious complications such as blood clots leading to stroke, heart attack, or blocked blood vessels.

3. Diagnosis of Polycythemia Vera

Doctors use several tests to confirm a PV diagnosis:

  • Blood Tests: Check red blood cell count, hematocrit levels (percentage of red blood cells in blood), white blood cell count, and platelet levels.
  • JAK2 Mutation Test: Determines if the patient carries the JAK2 gene mutation.
  • Bone Marrow Biopsy: Evaluates the bone marrow for excessive cell production.
  • Abdominal Ultrasound: Detects liver or spleen enlargement.

4. Treatment Options for Polycythemia Vera

Although PV has no definitive cure, treatment aims to control symptoms and prevent complications.

a. Phlebotomy (Bloodletting)

A primary treatment that reduces red blood cell levels, improves circulation, and lowers the risk of blood clots.

b. Bone Marrow Suppressing Medications

  • Hydroxyurea: Commonly used for high-risk patients to reduce red blood cell production.
  • Interferon-alpha: Helps suppress bone marrow activity and is often prescribed for pregnant women or those intolerant to Hydroxyurea.
  • Ruxolitinib (JAK2 Inhibitor): A targeted therapy for patients unresponsive to other treatments.

c. Supportive Treatments

  • Low-dose Aspirin: Reduces clotting risks.
  • Blood Pressure & Cholesterol Control: Prevents cardiovascular complications.
  • Healthy Diet & Regular Exercise: Supports overall well-being.

5. Lifestyle Recommendations for PV Patients

  • Regular health check-ups to monitor disease progression.
  • Stay hydrated to maintain healthy blood flow.
  • Avoid smoking and alcohol as they increase clotting risks.
  • Avoid extreme temperatures, as excessive heat or cold can worsen symptoms.
  • Seek medical attention immediately for severe headaches, numbness, or breathing difficulties.

6. Conclusion

Polycythemia Vera is a chronic blood disorder that can lead to severe complications if not managed properly. However, with appropriate treatment and a healthy lifestyle, patients can maintain a good quality of life. If you suspect you have PV, consult a healthcare provider for timely diagnosis and treatment.

Leave a Comment